The Patent Finder

Rowan University

46 patents currently held · Updated Nov 15, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

2
Ending by 2030
Apr 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 6 to 18, 2026 · next Dec 6
  • 1 fee due Feb 27, 2027
    The maintenance fee for Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of N-acetyl-aspartic acid (US 10,391,153) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
  • 2 fees due Apr 8 to 27, 2027 · next Apr 8
  • 1 fee due May 19, 2027
    The maintenance fee for Bandage and medical fabrics dispensers (US 10,478,357) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
  • 2 fees due Sep 29 to 30, 2027 · next Sep 29
  • 1 fee due Oct 7, 2027
    The maintenance fee for Processes of increasing crystallinity alignment of protein films and products thereof (US 10,611,888) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 17, 2026
  • 1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,809,631Targeting of podoplanin with lectin for use in the prevention and treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,114,593Cancer biomarker genes and gene products and methods for using the same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,664,687Diagnostic Autoantibody Profiles for the Detection and Diagnosis of Neurodegenerative Diseases
In force
 · High confidence
In forceHigh confidence
US 11,435,361Diagnostic Autoantibody Profiles for the Detection and Diagnosis of Neurodegenerative Diseases
In force
 · Medium confidence
In forceMedium confidence
US 9,169,327Targeting of podoplanin with lectin for use in the prevention and treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,132,817Diagnostic Biomarker Profiles for the Detection and Diagnosis of Alzheimer's Disease
In force
 · High confidence
In forceHigh confidence
US 9,746,482Diagnostic Biomarker Profiles for the Detection and Diagnosis of Parkinsons Disease
In force
 · High confidence
In forceHigh confidence
US 9,446,167Self-assembling biomimetic hydrogels having bioadhesive properties
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,649,338Use of silver-containing layers at implant surfaces
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,391,153Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of N-acetyl-aspartic acid
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 46 patents shown.
Pro members see all 46.
Pro members: see all 46 patents
Also on record, not counted in the 46: 4 patents in force now held by others · 5 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

17 pending · 12 abandoned · 34 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited